Related Experiment Videos
Generalized granuloma annulare and hepatitis B vaccination
1Dermatology Department, Hôpital de l'Antiquaille, rue de l'Antiquaille, 69321 Lyon Cedex 05, France.
European Journal of Dermatology : EJD
|September 5, 1998
Summary
Hepatitis B vaccination can rarely cause skin conditions like granuloma annulare. This case study details a patient who developed generalized granuloma annulare after a hepatitis B vaccine booster, which resolved with treatment.
Area of Science:
- Dermatology
- Immunology
- Vaccinology
Background:
- Hepatitis B vaccination is widespread in Europe, leading to increased reports of cutaneous adverse events.
- Cutaneous reactions post-vaccination warrant further investigation to understand their mechanisms and clinical presentation.
Observation:
- A 51-year-old woman developed generalized granuloma annulare.
- The onset of the skin condition occurred one month after receiving a hepatitis B vaccine booster.
- The patient experienced a recurrence of the same condition after a subsequent booster dose.
Findings:
- This is the first reported case of generalized granuloma annulare linked to hepatitis B immunization.
- Sulfone therapy effectively resolved the granuloma annulare lesions.
- The recurrence of the condition after a later booster suggests a potential causal relationship.
Implications:
- This case highlights a rare but notable adverse event associated with hepatitis B vaccination.
- Further research may be needed to elucidate the immunological link between hepatitis B vaccines and granuloma annulare.
- Clinicians should be aware of this potential cutaneous manifestation when administering hepatitis B vaccines.